tradingkey.logo

MiMedx Group Inc

MDXG
5.150USD
+0.120+2.39%
Cierre 02/06, 16:00ETCotizaciones retrasadas 15 min
762.59MCap. mercado
18.61P/E TTM

MiMedx Group Inc

5.150
+0.120+2.39%

Más Datos de MiMedx Group Inc Compañía

MiMedx Group, Inc. is a placental biologics company focused on providing a portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare. Its product portfolio categories include Wound Care and Surgical. The Wound Care products include EPIFIX and EPIEFFECT, which are marketed for external use, such as in advanced wound care applications. Its EPICORD, EPICORD Expandable and EPIEFFECT product lines also offer an alternative treatment option to address larger, deeper wounds. Its Surgical and Other product offering includes AMNIOFIX and AMNIOEFFECT, which are used in a variety of applications and surgical settings, including lower extremity repair, plastic surgery, vascular surgery and multiple orthopedic repairs and reconstructions. It also offers HELIOGEN, an advanced bovine collagen matrix containing type I and type III collagen that is intended for the management of moderately to heavily exudating wounds and to control minor bleeding.

Información de MiMedx Group Inc

Símbolo de cotizaciónMDXG
Nombre de la empresaMiMedx Group Inc
Fecha de salida a bolsaAug 20, 2007
Director ejecutivoCapper (Joseph H)
Número de empleados837
Tipo de seguridadOrdinary Share
Fin del año fiscalAug 20
Dirección1775 W Oak Commons Court, Ne
CiudadMARIETTA
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal30062
Teléfono17706519100
Sitio Webhttps://mimedx.com/
Símbolo de cotizaciónMDXG
Fecha de salida a bolsaAug 20, 2007
Director ejecutivoCapper (Joseph H)

Ejecutivos de MiMedx Group Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Joseph H. (Joe) Capper
Mr. Joseph H. (Joe) Capper
Chief Executive Officer, Director
Chief Executive Officer, Director
529.53K
+200000.00%
Mr. James L. Bierman
Mr. James L. Bierman
Independent Director
Independent Director
212.77K
+28609.00%
Ms. Ricci S. Whitlow
Ms. Ricci S. Whitlow
Executive Vice President, Chief Operating Officer
Executive Vice President, Chief Operating Officer
190.25K
-253782.00%
Dr. Cato T. Laurencin, M.D., Ph.D.
Dr. Cato T. Laurencin, M.D., Ph.D.
Independent Director
Independent Director
181.92K
+28609.00%
Ms. Dorothy E. Puhy
Ms. Dorothy E. Puhy
Independent Director
Independent Director
57.60K
+28609.00%
Ms. Kimberly (Kim) Maersk-Moller
Ms. Kimberly (Kim) Maersk-Moller
Chief Commercial Officer
Chief Commercial Officer
30.74K
-58300.00%
Mr. William Frank (Butch) Hulse, IV
Mr. William Frank (Butch) Hulse, IV
Chief Administrative Officer, General Counsel
Chief Administrative Officer, General Counsel
--
--
Dr. M. Kathleen Behrens Wilsey, Ph.D.
Dr. M. Kathleen Behrens Wilsey, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. K. Todd Newton
Mr. K. Todd Newton
Independent Director
Independent Director
--
--
Marty Sutter ,
Marty Sutter ,
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Joseph H. (Joe) Capper
Mr. Joseph H. (Joe) Capper
Chief Executive Officer, Director
Chief Executive Officer, Director
529.53K
+200000.00%
Mr. James L. Bierman
Mr. James L. Bierman
Independent Director
Independent Director
212.77K
+28609.00%
Ms. Ricci S. Whitlow
Ms. Ricci S. Whitlow
Executive Vice President, Chief Operating Officer
Executive Vice President, Chief Operating Officer
190.25K
-253782.00%
Dr. Cato T. Laurencin, M.D., Ph.D.
Dr. Cato T. Laurencin, M.D., Ph.D.
Independent Director
Independent Director
181.92K
+28609.00%
Ms. Dorothy E. Puhy
Ms. Dorothy E. Puhy
Independent Director
Independent Director
57.60K
+28609.00%
Ms. Kimberly (Kim) Maersk-Moller
Ms. Kimberly (Kim) Maersk-Moller
Chief Commercial Officer
Chief Commercial Officer
30.74K
-58300.00%

Desglose de ingresos

Divisa: USDActualizado: mar., 6 de ene
Divisa: USDActualizado: mar., 6 de ene
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
Por negocioUSD
Nombre
Ganancia
Proporción
Advanced Wound Care
77.10M
67.79%
Surgical
36.63M
32.21%
La empresa aún no ha revelado los datos relevantes.
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Advanced Wound Care
77.10M
67.79%
Surgical
36.63M
32.21%

Estadísticas de accionistas

Actualizado: dom., 16 de nov
Actualizado: dom., 16 de nov
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
EW Healthcare Partners
19.04%
BlackRock Institutional Trust Company, N.A.
5.90%
Trigran Investments, Inc.
5.20%
The Vanguard Group, Inc.
4.83%
First Light Asset Management, LLC
2.47%
Otro
62.56%
Accionistas
Accionistas
Proporción
EW Healthcare Partners
19.04%
BlackRock Institutional Trust Company, N.A.
5.90%
Trigran Investments, Inc.
5.20%
The Vanguard Group, Inc.
4.83%
First Light Asset Management, LLC
2.47%
Otro
62.56%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor/Hedge Fund
19.08%
Investment Advisor
19.07%
Venture Capital
19.04%
Hedge Fund
11.72%
Research Firm
2.14%
Individual Investor
1.79%
Pension Fund
0.61%
Bank and Trust
0.33%
Insurance Company
0.03%
Otro
26.20%

Participación institucional

Actualizado: jue., 1 de ene
Actualizado: jue., 1 de ene
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q4
455
106.79M
72.11%
-3.01M
2025Q3
443
104.90M
70.83%
-3.83M
2025Q2
451
106.45M
71.95%
-3.98M
2025Q1
460
106.92M
72.40%
-5.30M
2024Q4
455
107.57M
73.21%
-3.01M
2024Q3
429
103.18M
70.48%
-6.90M
2024Q2
424
100.59M
68.44%
-3.52M
2024Q1
405
106.53M
74.65%
+1.42M
2023Q4
391
100.91M
86.85%
+27.80M
2023Q3
385
72.00M
62.20%
-22.83M
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
EW Healthcare Partners
28.20M
19.04%
--
--
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
8.73M
5.9%
-75.29K
-0.85%
Sep 30, 2025
Trigran Investments, Inc.
7.70M
5.2%
-689.43K
-8.22%
Sep 30, 2025
The Vanguard Group, Inc.
6.78M
4.58%
-155.61K
-2.24%
Sep 30, 2025
First Light Asset Management, LLC
3.65M
2.47%
+1.73M
+89.52%
Sep 30, 2025
State Street Investment Management (US)
3.59M
2.43%
+128.69K
+3.71%
Sep 30, 2025
Geode Capital Management, L.L.C.
2.84M
1.92%
+789.00
+0.03%
Sep 30, 2025
Paradigm Capital Management, Inc.
2.65M
1.79%
-1.80M
-40.45%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
2.38M
1.61%
+99.08K
+4.34%
Sep 30, 2025
Cannell Capital, LLC
2.01M
1.36%
-60.09K
-2.90%
Sep 30, 2025
Ver más

ETFs relacionados

Actualizado: mar., 2 de dic
Actualizado: mar., 2 de dic
Nombre
Proporción
Invesco NASDAQ Future Gen 200 ETF
0.58%
Janus Henderson Small Cap Growth Alpha ETF
0.56%
First Trust Small Cap Growth AlphaDEX Fund
0.3%
iShares Micro-Cap ETF
0.17%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.16%
Franklin US Small Cap Multifactor Index ETF
0.15%
Vanguard US Quality Factor ETF
0.14%
WisdomTree US SmallCap Quality Growth Fund
0.14%
VictoryShares Small Cap Free Cash Flow ETF
0.12%
State Street SPDR S&P Biotech ETF
0.12%
Ver más
Invesco NASDAQ Future Gen 200 ETF
Proporción0.58%
Janus Henderson Small Cap Growth Alpha ETF
Proporción0.56%
First Trust Small Cap Growth AlphaDEX Fund
Proporción0.3%
iShares Micro-Cap ETF
Proporción0.17%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proporción0.16%
Franklin US Small Cap Multifactor Index ETF
Proporción0.15%
Vanguard US Quality Factor ETF
Proporción0.14%
WisdomTree US SmallCap Quality Growth Fund
Proporción0.14%
VictoryShares Small Cap Free Cash Flow ETF
Proporción0.12%
State Street SPDR S&P Biotech ETF
Proporción0.12%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
KeyAI